Ellen Rose

Ellen Rose is an accomplished communications professional with extensive experience in corporate communications and investor relations. Currently serving as Senior Vice President of Communications & Investor Relations at Lyell Immunopharma since April 2021, Ellen previously held key positions at Prothena Corporation plc and Johnson & Johnson Innovation, among others. Notable roles include Senior Vice President of Communications and Chief of Staff at Prothena and Director of Corporate Communications at ALZA/Johnson & Johnson. Ellen's expertise is supported by a Bachelor of Arts in International Relations from Stanford University.